Rajiv Chopra1,2, Michael Bronskill1,2,
Masoom Haider3,4, Laurence Klotz5,6
1Imaging Research, Sunnybrook Health
Sciences Centre, Toronto, Ontario, Canada; 2Medical Biophysics,
University of Toronto, Toronto, Ontario, Canada; 3Medical Imaging,
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; 4Medical
Imaging, University of Toronto, Toronto, Ontario, Canada; 5Urology,
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; 6Surgery,
University of Toronto, Toronto, Ontario, Canada
MRI-guided
transurethral ultrasound therapy is a minimally-invasive treatment for
localized prostate cancer. The purpose of this study was to evaluate the
feasibility of performing this treatment in humans. An initial clinical
evaluation in prostate cancer patients destined for radical prostatectomy was
performed. The predicted thermal damage zone was compared with the actual
tissue damage measured on histology.